Affiliation:
1. From the Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY; the Department of Quantitative Health Sciences Cleveland Clinic, Cleveland, OH; and the Departmento de Cirurgia, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Abstract
PurposeLymph node metastasis is a multifactorial event. Several variables have been described as predictors of lymph node metastasis in breast cancer. However, it is difficult to apply these data—usually expressed as odds ratios—to calculate the probability of sentinel lymph node (SLN) metastasis for a specific patient. We developed a user-friendly prediction model (nomogram) based on a large data set to assist in predicting the presence of SLN metastasis.Patients and MethodsClinical and pathologic features of 3,786 sequential SLN biopsy procedures were assessed with multivariable logistic regression to predict the presence of SLN metastasis in breast cancer. The model was subsequently applied to 1,545 sequential SLN biopsies. A nomogram was created from the logistic regression model. A computerized version of the nomogram was developed and is available on the Memorial Sloan-Kettering Cancer Center (New York, NY) Web site.ResultsAge, tumor size, tumor type, lymphovascular invasion, tumor location, multifocality, and estrogen and progesterone receptors were associated with SLN metastasis in multivariate analysis. The nomogram was accurate and discriminating, with an area under the receiver operating characteristic curve of 0.754 when applied to the validation group.ConclusionNewly diagnosed breast cancer patients are increasingly interested in information about their disease. This nomogram is a useful tool that helps physicians and patients to accurately predict the likelihood of SLN metastasis.
Publisher
American Society of Clinical Oncology (ASCO)
Reference60 articles.
1. Association of Directors of Anatomical and Surgical Pathology: Recommendations for the reporting of breast carcinoma: Association of Directors of Anatomic and Surgical Pathology. Hum Pathol 27:220,1996-224,
2. Clark GM: Prognostic and predictive factors, in Harris JR, Lippman ME, Morrow M, et al (eds): Diseases of the Breast (ed 1). Philadelphia, PA, Lippincott, Williams & Wilkins, pp 461,1996-485
3. Early Breast Cancer Trialists Collaborative Group: Multi-agent chemotherapy for early breast cancer. Cochrane Database Syst Rev:CD000487 , 2002
4. Carlson RW, McCormick B: Update: NCCN breast cancer Clinical Practice Guidelines. J Natl Compr Canc Netw 3:S7,2005-S11, (suppl 1)
5. The Risk of Axillary Relapse After Sentinel Lymph Node Biopsy for Breast Cancer Is Comparable With That of Axillary Lymph Node Dissection